News

Sun Life Financial Inc.  SLF hit a 52-week high of $65.28 on June 3. Shares closed at $64.91 after gaining 9.4% year to date, outperforming the industry, the sector and the Zacks S&P 500 composite.

U.S. President Donald Trump does it again. In a bid to protect American industry, he has doubled down, literally, on his favorite economic weapon — tariffs. Effective today, the United States has

Shares of HNI (HNI) have gained 8.8% over the past four weeks to close the last trading session at $47.26, but there could still be a solid upside left in the stock if short-term price targets of

Shares of Knot Offshore (KNOP) have gained 0.3% over the past four weeks to close the last trading session at $6.39, but there could still be a solid upside left in the stock if short-term price

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 6.1% over the past four weeks to close the last trading session at $7.69, but there could still be a solid upside left in the stock if

Rambus (RMBS) closed the last trading session at $56.30, gaining 12.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Energy Transfer LP (ET) closed the last trading session at $17.90, gaining 13.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Zymeworks Inc. (ZYME) closed the last trading session at $12.08, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

FTAI Aviation (FTAI) closed the last trading session at $123.35, gaining 14.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Agenus (AGEN) have gained 68.4% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets of

Amneal Pharmaceuticals (AMRX) closed the last trading session at $7.45, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) closed the last trading session at $13.36, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Dutch Bros Inc. BROS continues to benefit from robust revenue growth and store expansion efforts. However, rising costs continue to challenge its path to higher profitability.In the first quarter of

CrowdStrike Holdings, Inc. CRWD reported non-GAAP earnings per share of 73 cents for the first quarter of fiscal 2026, which surpassed the Zacks Consensus Estimate by 10.61% and came ahead of